优思丽 (u-Slim)
产品简介

这种控制体重的新型膳食补充剂来自藤黄果,是由其干果皮提取的最佳剂量的Super CitriMax®( - )羟基柠檬酸。 乔治敦大学的研究人员进行的随机,双盲,安慰剂对照的临床研究表明,每天服用3次,每次1,500毫克的Super CitriMax在控制体重,增加脂肪燃烧,改变胆固醇水平和降低体重指数方面比单独节食和运动减肥的效果强3倍。*
Super CitriMax®含有60%羟基柠檬酸(HCA)水提取物。 它独特地与钙和钾结合,以获得最大的稳定性,溶解性,生物利用度和体重控制功效。 Super CitriMax®是一个知名品牌,受美国发明专利保护,获得四项临床研究和全面安全性实验的支持。 已发表的临床研究包括:减肥,食欲控制,减少热量和脂质调节。 已发表的研究还证实了Super CitriMax®在人类的生物利用度。*
优思丽产品的特点:
- 比单独节食和运动减肥的效果强3倍*
- 血清素水平增加44%*
- 每日卡路里摄入量减少25%*
- 通过美国Self-Affirmed GRAS认证
更多专业研究请参阅《临床研究》
本产品诚招经销商和批发商
- * 本声明未经美国食品药品管理局评估。 本产品不用于诊断,治疗或预防任何疾病。 本网站提供的信息仅供您一般参考,不能代替专业医疗建议或针对特定疾病的治疗。
临床研究
Here, you can read some of important published clinical research papers about Super CitriMax®, which support weight management. Published peer reviewed studies can be accessed through PubMed at www.ncbi.nlm.nih.gov/pubmed. For more information, please contact Renylin Bio-Health Inc.
Super CitriMax Treatment Reduced 24 h Energy Intake in Humans While Satiety Was Sustained
The effect of (-)-hydroxycitrate on
energy intake and satiety in overweight humans
Abstract
Objective: Assessment of the effects of 2 weeks of daily administration of HCA on energy intake and satiety in overweight men and women.
Design: A 6-week randomized placebo-controlled single-blinded cross-over trial.
Subjects: consumed three times daily for 2 weeks 100 ml tomato juice (placebo) and, separated by a 2 week wash-out period, 100 ml tomato juice with 300 mg HCA.Subjects: Twelve males and 12 females (body mass index 27.5+/-2.0 kg/m(2); age 37+/-10 y).
Mesurements: After 2 weeks, 24 h energy intake (EI), appetite profile, hedonics, mood and possible change in dietary restraint were assessed in the laboratory restaurant. Prevention of degradation and bio-availability was documented.
Results: Twenty-four-hour EI was decreased by 15-30% (P<0.05) with HCA treatment compared to placebo, without changes in the appetite profile, dietary restraint, mood, taste perception and hedonics, while body weight tended to decrease (P=0.1).
Conclusion: HCA treatment reduced 24 h EI in humans while satiety was sustained.
Source:
Westerterp-Plantenga MS, Kovacs EM.
Int J Obes Relat Metab Disord. 2002 Jun;26(6):870-2
www.ncbi.nlm.nih.gov/pubmed/12037659
Super CitriMax – Preuss, et al. Diabetes Obes Metab. 2004.
Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX)
and a combination of HCA-SX plus niacin-bound chromium
and Gymnema sylvestre extract on weight loss.
Abstract
AIM: The efficacy of optimal doses of highly bioavailable (-)-hydroxycitric acid (HCA-SX) alone and in combination with niacin-bound chromium (NBC) and a standardized Gymnema sylvestre extract (GSE) on weight loss in moderately obese subjects was evaluated by monitoring changes in body weight, body mass index (BMI), appetite, lipid profiles, serum leptin and excretion of urinary fat metabolites. HCA-SX has been shown to reduce appetite, inhibit fat synthesis and decrease body weight without stimulating the central nervous system. NBC has demonstrated its ability to maintain healthy insulin levels, while GSE has been shown to regulate weight loss and blood sugar levels.
METHODS: A randomized, double-blind, placebo-controlled human study was conducted in Elluru, India for 8 weeks in 60 moderately obese subjects (ages 21-50, BMI >26 kg/m(2)). Subjects were randomly divided into three groups. Group A was administered HCA-SX 4667 mg, group B was administered a combination of HCA-SX 4667 mg, NBC 4 mg and GSE 400 mg, while group C was given placebo daily in three equally divided doses 30-60 min before meals. All subjects received a 2000 kcal diet/day and participated in supervised walking.
RESULTS: At the end of 8 weeks, body weight and BMI decreased by 5-6% in both groups A and B. Food intake, total cholesterol, low-density lipoproteins, triglycerides and serum leptin levels were significantly reduced in both groups, while high-density lipoprotein levels and excretion of urinary fat metabolites increased in both groups. A marginal or non-significant effect was observed in all parameters in group C.
CONCLUSION: The present study shows that optimal doses of HCA-SX and, to a greater degree, the combination of HCA-SX, NBC and GSE can serve as an effective and safe weight-loss formula that can facilitate a reduction in excess body weight and BMI, while promoting healthy blood lipid levels.
Source:
Preuss HG, Bagchi D, Bagchi M,Rao CV,Dey DK, Satyanarayana S.
PubMed. 2004 May; 6(3):171-80.
www.ncbi.nlm.nih.gov/pubmed/15056124
Super CitriMax is A Highly Effective Adjunct to Healthy Weight Control
Efficacy of a novel calcium/potassium salt of
(-)-hydroxycitric acid in weight control.
Abstract
The weight-loss efficacy of a novel, water-soluble, calcium-potassium salt of (-)-hydroxycitric acid (HCA-SX) was re-examined in 90 obese subjects (BMI: 30-50.8 kg/m2). We combined data from two previously reported randomized, double-blind, placebo-controlled clinical studies in order to achieve a better statistical evaluation based on a larger population. This re-examination of data also allowed us to reflect more intensely on various aspects of weight loss studies. Subjects were randomly divided into three groups: group A received a daily dose of HCA-SX 4, 667 mg (providing 2,800 mg HCA per day); group B was given a daily dose of a combination of HCA-SX 4,667 mg, niacin-bound chromium (NBC) 4 mg (providing 400 microg elemental chromium), and Gymnema sylvestre extract (GSE) 400 mg (providing 100 mg gymnemic acid); and group C received a placebo in three equally divided doses 30-60 min before each meal. All subjects were provided a 2,000 kcal diet/day and participated in a supervised walking program for 30 min/day, 5 days/week. Eighty-two subjects completed the study. At the end of 8 weeks, in group A, both body weight and BMI decreased by 5.4%, low-density lipoprotein and triglycerides levels were reduced by 12.9% and 6.9%, respectively, while high-density lipoprotein levels increased by 8.9%, serum leptin levels decreased by 38%, serotonin levels increased by 44.5% and urinary excretion of fat metabolites increased by 32-109%. Group B demonstrated similar beneficial changes, but generally to a greater extent. No significant adverse effects were observed. The combined results confirm that HCA-SX and, to a greater degree, the combination of HCA-SX plus NBC and GSE reduce body weight and BMI, suppress appetite, improve blood lipid profiles, increase serum leptin and serotonin levels and increase fat oxidation more than placebo. We conclude that dosage levels, timing of administration, subject compliance and bioavailability of HCA-SX significantly affect results and that when taken as directed, HCA-SX is a highly effective adjunct to healthy weight control.
Source:
Preuss HG, Garis RI, Bramble JD, Bagchi D,Bagchi M, Rao CV, Satyanarayana S
PubMed. Int J Clin Pharmacol Res. 2005;25(3):133-44.
www.ncbi.nlm.nih.gov/pubmed/16366421
Super CitriMax – Preuss, et al. Nutr Res. 2004.
Efficacy of a novel, natural extract of (–)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX, niacin-bound chromium and Gymnema sylvestre extract in weight management in human volunteers: a pilot study
Abstract:
In this pilot study, the efficacy of a novel, natural extract of a highly bioavailable, calcium-potassium salt of (–)-hydroxycitric acid (HCA-SX) alone and in combination with a niacin-bound chromium (NBC) and Gymnema sylvestra extract (GSE) was evaluated for weight loss in moderately obese subjects by monitoring changes in body weight, body mass index (BMI), appetite, lipid profiles, serum leptin and serotonin levels, and enhanced excretion of urinary fat metabolites. Garcinia cambogia-derived (–)-hydroxycitric acid (HCA) has been shown to reduce appetite, inhibit fat synthesis and decrease body weight without stimulating the central nervous system. NBC has shown the ability to restore insulin function, metabolize fat, turn protein into muscle, and convert sugar into energy, which plays a role in appetite regulation and facilitates weight loss. Gymnema sylvestre is a traditional herb that helps to promote weight loss possibly through its ability to reduce cravings for sweets and control blood sugar levels. A randomized, double-blind, placebo-controlled human clinical study was conducted in thirty obese subjects (ages 21-50, BMI>26 kg/m2) for eight weeks in Elluru, India. The subjects were randomly divided into three groups (10 subjects/group) and given HCA-SX 4,667 mg (60% HCA providing 2,800 mg HCA/day) (Group A), a combination of HCA-SX 4,667 mg, NBC 4 mg (providing 400 μg elemental Cr) and GSE 400 mg (providing 100 mg gymnemic acid) (Group B), or placebo (Group C) daily in 3 equally divided doses 30-60 min before each meal. This HCA-SX dose was extrapolated from previously conducted in vitro and in vivo studies. In addition, subjects received 2,000 kcal diet/day and underwent a 30 min/day supervised walking program, 5 days/week. At the end of 8 weeks, body weight and BMI decreased by 6.3%, respectively, in Group A. Food intake was reduced by 4%. Total cholesterol, LDL and triglycerides levels were reduced by 6.3%, 12.3% and 8.6%, respectively, while HDL and serotonin levels increased by 10.7% and 40%, respectively. Serum leptin levels were decreased by 36.6%, and the enhanced excretion of urinary fat metabolites, including malondialdehyde (MDA), acetaldehyde (ACT), formaldehyde (FA) and acetone (ACON), increased by 125-258%. Under these same conditions, Group B reduced body weight and BMI by 7.8% and 7.9%, respectively. Food intake was reduced by 14.1%. Total cholesterol, LDL and triglyceride levels were reduced by 9.1%, 17.9% and 18.1%, respectively, while HDL and serotonin levels increased by 20.7% and 50%, respectively. Serum leptin levels decreased by 40.5% and enhanced excretion of urinary fat metabolites increased by 146-281%. Group C reduced body weight and BMI by only 1.6% and 1.7%, respectively, food intake was increased by 2.8%, and LDL, triglycerides and total cholesterol decreased by 0.8%, 0.2% and 0.8%, respectively. HDL were reduced by 4.1% while serum leptin levels were increased by 0.3%, and excretion of urinary fat metabolites did not change in MDA, ACT and FA, and marginally increased in the case of ACON. No adverse effects were observed. Results demonstrate that HCA-SX and, to a greater degree, the combination of HCA-SX, NBC and GSE can serve as safe weight management supplements.
Source:
Harry G Preuss, Debasis Bagchi, Manashi Bagchi, C.V. Sanyasi Rao, S Satyanarayana, Dipak K Dey
Nutrition Research. January 2004 Volume 24, Issue 1, Pages 45–58
www.sciencedirect.com/science/article/pii/S0271531703002215
精选问答
SuperCitriMax®是瑞尼琳牌优思丽减肥胶囊的活性成分。 SuperCitriMax®含有来自藤黄果干果皮的60%羟基柠檬酸(HCA)。 它与必需矿物质钙和钾结合,以获得最大的稳定性,溶解性,生物利用度和功效。.
SuperCitriMax®荣获八项美国和国际专利,以及二十多项待批专利申请,涉及160多种组分,工艺和使用方法。
经临床试验证明SuperCitriMax®具有:
- 1. 减肥比单独节食和运动的效果强三倍*
- 2. 降低体质指数(BMI)比单独节食和运动的效果强三倍*
- 3. 增加脂肪燃烧*
- 4. 降低食欲*
- 5. 热量摄入减少25%*
- 6. 提高血清素水平*
- 7. 降低胆固醇含量*
- 8. 良好的补钙源*
Super CitriMax是唯一可以提高血清5-羟色胺水平的羟基柠檬酸(HCA)成分,血清素是一种参与食欲控制的神经递质,有助于减少热量摄入,增加饱腹感,控制食量大小,解决人们面临的许多情绪问题,包括暴饮暴食吃。*
Super CitriMax已被证明可以通过分解脂肪细胞周围的围脂滴蛋白质层来燃烧脂肪(只有受专利保护的HCA成分可以燃烧脂肪)。 这有利于脂肪滴的分散和体脂的燃烧,其中包括棕色脂肪,棕色脂肪是最难消除的脂肪。*
与抑制碳水化合物吸收的碳水化合物阻滞剂不同,Super CitriMax实际上是通过暂时抑制ATP-柠檬酸裂解酶(柠檬酸裂解酶)来阻断碳水化合物在细胞水平上转化为脂肪和胆固醇。*
Super CitriMax®100%纯天然,安全无毒,可以放心服用。*
- Super CitriMax®来自藤黄果(Garcinia cambogia)的干果皮,这是一种原产于东南亚的植物,干燥的果皮已经使用了几个世纪,它可以使我们的饮食感觉更加“饱腹”。藤黄果被列入美国农业部多年生食用水果清单。
- Super CitriMax®由标准水平的( - ) - 羟基柠檬酸(HCA)组成,这种有机酸类似于柑橘类水果中的柠檬酸,但具有非常不同的特性。临床证明HCA可以抑制食欲,减少食物摄入,燃烧脂肪和抑制脂肪合成。
- Super CitriMax®不会刺激中枢神经系统或也不会引起与饮食兴奋剂(如咖啡因)相关的失眠,紧张或快速心率等副作用。
Super CitriMax®经过了11项临床和亚临床的专项研究,这些研究包括:*
- 功效人体试验:乔治城大学医学中心
- 饱足感人体试验:马斯特里赫特大学,荷兰人类生物学系
- 人体血清素水平研究:休斯顿大学药学院
- 脂肪燃烧/氧化 - 细胞培养:俄亥俄州立大学医学中心
- 生物利用度人体试验:加州大学营养科学系
- 动物安全试验:Creighton大学医学中心
- 能源消耗动物试验:瑞士理工学院动物科学研究所
- 神经递质动物试验:Creighton大学医学中心
- 基因表达研究:俄亥俄州立大学医学中心
经美国Burdock集团确认Super CitriMax®符合美国FDA制定的GRAS安全食品标准,并且确认Super CitriMax®是诸多羟基酸(HCA)产品中唯一符合GRAS认证的产品。Burdock集团是评估食品和饮料成分安全性的全国领先的毒理学专家。
- * 本声明未经美国食品药品管理局评估。 本产品不用于诊断,治疗或预防任何疾病。 本网站提供的信息仅供您一般参考,不能代替专业医疗建议或针对特定疾病的治疗。